UK-based AI-first drug design and development company.
Startup Funding News
New startup rounds, lead investors and the businesses behind the funding.
54 rounds · $4.8B disclosed · $33.4M median
| Company | Amount | Stage / sector | Lead investor | Announced |
|---|---|---|---|---|
| Isomorphic Labs UK-based AI-first drug design and development company. | $2.1B | Series B Healthtech | Thrive Capital | |
| ALP Bio AG to accelerate their platform which combines human immune organoid biology with generative AI to help antibody developers identify, understand, and reduce immunogenicity risk earlier in drug development. | €1.9M | Pre-seed Healthtech | — | |
| auryx auryx is on a mission to create the world’s best foundation model for turning sound into health insights. | $2M | Pre-seed Healthtech | — | |
| Hypervision Surgical Hypervision Surgical develops computer-assisted tissue analysis tools for surgeons. | £17M | Series A Healthtech | — | |
| mbiomics mbiomics develops microbiome analysis technology to inform targeted therapies. | €12M | Series A Healthtech | — | |
| Primogene Leipzig-based BioTech startup enabling the sustainable and scalable manufacturing of complex, high-value molecules. | €4.1M | Seed Healthtech | — | |
| tacalyx Tacalyx is a biotech company focused on the discovery and development of novel anti-TACA. | €11M | Seed Healthtech | — | |
| TietAI the Spanish company's goal is to transform the technological foundation on which hospitals operate. | €2.5M | Seed Healthtech | — | |
| dehaze Munich-based healthtech AI company. | €3.2M | Seed Healthtech | — | |
| Cerca Magnetics UK-based MedTech startup developing wearable brain imaging systems using quantum sensing technology. | €4.3M | Series A Healthtech | — | |
| Storm Therapeutics A biotechnology company developing small molecule drugs that target RNA modifying enzymes for the treatment of cancer. | $56M | Series C+ Healthtech | — | |
| Oxford Medical Simulation Virtual reality (VR) training platform for healthcare professionals. | €5.8M | Growth Healthtech | — | |
| Vitestro Utrecht, Netherlands-based developer of an autonomous blood drawing device. | $70M | Series B Healthtech | — | |
| Polares Medical Polares medical is a medical device company with a novel device for treating mitral valve regurgitation. | $50M | Series C+ Healthtech | — | |
| Oska Health a hybrid care provider combining personal health coaches with AI. | €11M | Seed Healthtech | — | |
| nyra health digital therapy platform for neurological patients. | €20M | Series A Healthtech | — | |
| Turbine Turbine's platform understands the inner mechanisms of cancer enabling the discovery of novel targets & precision medicinal therapies. | $25M | Series B Healthtech | — | |
| Centauri immunotherapy company with a proprietary platform technology applicable across a wide range of therapeutic areas. | £30M | Series A Healthtech | — | |
| Patientdesk.ai Proven in dental scheduling, now expanding to insurance, payments, and care coordination. Already live across 35+ locations with 3 major chains while building. | $1M | Pre-seed Healthtech | — | |
| Neurent Medical the company behind NEUROMARK, a minimally invasive solution to treat chronic rhinitis. | €62.5M | Series C+ Healthtech | — | |
| Aerska Aerska has developed an antibody-oligonucleotide conjugate (AOC) platform that uses “brain shuttles” to help deliver RNAi directly to the brain, allowing for better uptake by neurons and lasting gene knockdown. | $39M | Series A Healthtech | — | |
| Biorce a TechBio company focused on transforming clinical trials through artificial intelligence. | $52M | Series A Healthtech | — | |
| Automata Technologies Biotech company that offers robotic automation solutions to life sciences labs. | $45M | Series C+ Healthtech | — | |
| Evaro A digital health startup that offers AI-powered clinical and drug prescription services for minor conditions. | $25M | Series A Healthtech | — | |
| Altavo Giving voiceless people an individual, natural sounding voice. | €3M | Series A Healthtech | — |
to accelerate their platform which combines human immune organoid biology with generative AI to help antibody developers identify, understand, and reduce immunogenicity risk earlier in drug development.
auryx is on a mission to create the world’s best foundation model for turning sound into health insights.
Hypervision Surgical develops computer-assisted tissue analysis tools for surgeons.
mbiomics develops microbiome analysis technology to inform targeted therapies.
Leipzig-based BioTech startup enabling the sustainable and scalable manufacturing of complex, high-value molecules.
Tacalyx is a biotech company focused on the discovery and development of novel anti-TACA.
the Spanish company's goal is to transform the technological foundation on which hospitals operate.
Munich-based healthtech AI company.
UK-based MedTech startup developing wearable brain imaging systems using quantum sensing technology.
A biotechnology company developing small molecule drugs that target RNA modifying enzymes for the treatment of cancer.
Virtual reality (VR) training platform for healthcare professionals.
Utrecht, Netherlands-based developer of an autonomous blood drawing device.
Polares medical is a medical device company with a novel device for treating mitral valve regurgitation.
a hybrid care provider combining personal health coaches with AI.
digital therapy platform for neurological patients.
Turbine's platform understands the inner mechanisms of cancer enabling the discovery of novel targets & precision medicinal therapies.
immunotherapy company with a proprietary platform technology applicable across a wide range of therapeutic areas.
Proven in dental scheduling, now expanding to insurance, payments, and care coordination. Already live across 35+ locations with 3 major chains while building.
the company behind NEUROMARK, a minimally invasive solution to treat chronic rhinitis.
Aerska has developed an antibody-oligonucleotide conjugate (AOC) platform that uses “brain shuttles” to help deliver RNAi directly to the brain, allowing for better uptake by neurons and lasting gene knockdown.
a TechBio company focused on transforming clinical trials through artificial intelligence.
Biotech company that offers robotic automation solutions to life sciences labs.
A digital health startup that offers AI-powered clinical and drug prescription services for minor conditions.
Giving voiceless people an individual, natural sounding voice.
Reports & briefings
September 2026 Startup Funding Report
49 funding rounds and $6.6B disclosed. Mistral AI leads the edition; explore the companies, investors and stage breakdown.
Sep 21 – 27, 2026 Startup Funding Weekly
23 funding rounds and $1.2B disclosed. TEKEVER leads the edition; explore the companies, investors and stage breakdown.
Sep 14 – 20, 2026 Startup Funding Weekly
3 European funding rounds and $387.8M disclosed. EUCLYD leads the edition; explore the companies, investors and stage breakdown.
Active investors
| Investor | Rounds | Led | Recent investments |
|---|---|---|---|
| 01General Catalyst | 13 | 1 | DwellyNeko Health |
| 02Balderton Capital | 12 | 1 | SpottThe Exploration Company |
| 03Y Combinator | 12 | 0 | SpottConveo |
| 04British Business Bank | 11 | 0 | Certain EnergyAlchemab Therapeutics |